nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile
|
Salmeron-Villalobos, Julia |
|
|
6 |
16 |
p. 4661-4674 |
artikel |
2 |
CD34 + -selected stem cell boost can safely improve cytopenias following CAR T-cell therapy
|
Mullanfiroze, Khushnuma |
|
|
6 |
16 |
p. 4715-4718 |
artikel |
3 |
Cellular distribution of mutations and association with disease risk in Langerhans cell histiocytosis without BRAF V600E
|
Milne, Paul |
|
|
6 |
16 |
p. 4901-4904 |
artikel |
4 |
Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis
|
Shafagati, Nazila |
|
|
6 |
16 |
p. 4740-4762 |
artikel |
5 |
Cytokine pathway variants modulate platelet production: IFNA16 is a thrombocytosis susceptibility locus in humans
|
Gnatenko, Dmitri V. |
|
|
6 |
16 |
p. 4884-4900 |
artikel |
6 |
Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy
|
Hasan, Aisha N. |
|
|
6 |
16 |
p. 4859-4872 |
artikel |
7 |
Editorial Board
|
|
|
|
6 |
16 |
p. i |
artikel |
8 |
Emerging clinical trial designs may accelerate translation in hematology: lessons from COVID-19
|
Neal, Matthew D. |
|
|
6 |
16 |
p. 4710-4714 |
artikel |
9 |
HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition
|
Moison, Céline |
|
|
6 |
16 |
p. 4793-4806 |
artikel |
10 |
ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis
|
Giustozzi, Michela |
|
|
6 |
16 |
p. 4873-4883 |
artikel |
11 |
ICOS immunoPET enables visualization of activated T cells and early diagnosis of murine acute gastrointestinal GvHD
|
Xiao, Zunyu |
|
|
6 |
16 |
p. 4782-4792 |
artikel |
12 |
Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study
|
Alderuccio, Juan P. |
|
|
6 |
16 |
p. 4736-4739 |
artikel |
13 |
Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma
|
Jaeger, Ulrich |
|
|
6 |
16 |
p. 4816-4820 |
artikel |
14 |
Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma
|
Little, Jessica S. |
|
|
6 |
16 |
p. 4821-4830 |
artikel |
15 |
Nurselike cells sequester B cells in disorganized lymph nodes in chronic lymphocytic leukemia via alternative production of CCL21
|
Zaaboub, Rim |
|
|
6 |
16 |
p. 4691-4704 |
artikel |
16 |
Prospective external validation of biomarkers to predict acute graft-versus-host disease severity
|
Robin, Marie |
|
|
6 |
16 |
p. 4763-4772 |
artikel |
17 |
Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study
|
Lesueur, Paul |
|
|
6 |
16 |
p. 4807-4815 |
artikel |
18 |
Revision of RUNX1 variant curation rules
|
Feurstein, Simone |
|
|
6 |
16 |
p. 4726-4730 |
artikel |
19 |
Rural-urban disparities in place of death in hematologic malignancies in the United States, 2003 to 2019
|
Hussaini, S. M. Qasim |
|
|
6 |
16 |
p. 4731-4734 |
artikel |
20 |
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
|
Rejeski, Kai |
|
|
6 |
16 |
p. 4719-4725 |
artikel |
21 |
Sexual violence as a precipitator of chronic pain in young adults with sickle cell disease
|
Chopra, Maya |
|
|
6 |
16 |
p. 4831-4833 |
artikel |
22 |
Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease
|
van Rhee, Frits |
|
|
6 |
16 |
p. 4773-4781 |
artikel |
23 |
Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma
|
Colombo, Anthony R. |
|
|
6 |
16 |
p. 4675-4690 |
artikel |
24 |
The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS
|
Hofman, Isabel Juliana F. |
|
|
6 |
16 |
p. 4705-4709 |
artikel |
25 |
The odyssey of pacritinib in myelofibrosis
|
Venugopal, Sangeetha |
|
|
6 |
16 |
p. 4905-4913 |
artikel |
26 |
Traumatic vessel injuries initiating hemostasis generate high shear conditions
|
Yakusheva, Alexandra A. |
|
|
6 |
16 |
p. 4834-4846 |
artikel |
27 |
Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis
|
Vogiatzi, Fotini |
|
|
6 |
16 |
p. 4847-4858 |
artikel |
28 |
Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229.
|
|
|
|
6 |
16 |
p. 4735 |
artikel |